4//SEC Filing
Wargacki Stephen 4
Accession 0001214659-24-004302
CIK 0001398733other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 10:34 AM ET
Size
9.8 KB
Accession
0001214659-24-004302
Insider Transaction Report
Form 4
Wargacki Stephen
Chief Science Officer
Transactions
- Award
Common Stock
2024-03-07+112,500→ 270,919 total - Award
Non-Qualified Stock Option (right to buy)
2024-03-07+56,250→ 56,250 totalExercise: $5.68Exp: 2034-03-07→ Common Stock (56,250 underlying) - Tax Payment
Common Stock
2023-03-10$0.79/sh−1,981$1,572→ 158,419 total
Footnotes (4)
- [F1]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.
- [F2]The original Form 3, filed on 1/1/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares vested that occurred on 3/10/22 as a total of 4,663 shares vested and owned when in fact 3,107 shares of the Issuer's common stock were owned, net of taxes withheld. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 1,556 shares reflecting share withheld for the payment of taxes.
- [F3]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
- [F4]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001960165
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 10:34 AM ET
- Size
- 9.8 KB